Amanote Research

Amanote Research

    RegisterSign In

Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma From a Costello Syndrome Patient

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2017.00042
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

April 3, 2017

Authors
Donna M. CartledgeKatherine M. RobbinsKatherine M. DrakeRachel SternbergDeborah L. StableyKaren W. GrippE. Anders KolbKatia Sol-ChurchAndrew D. Napper
Publisher

Frontiers Media SA


Related search

Embryonal Rhabdomyosarcoma – A Case Series

Pathology
Forensic MedicinePathology
2020English

Primary “Botryoid” Embryonal Rhabdomyosarcoma in Mesentery

Turk Patoloji Dergisi
Forensic MedicinePathology
2011English

Adipocyte-Like Differentiation in a Posttreatment Embryonal Rhabdomyosarcoma

Case Reports in Pathology
2015English

Embryonal Rhabdomyosarcoma of the Orbit

Neurologia Medico-Chirurgica
SurgeryNeurology
1980English

Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

A Case of Embryonal Rhabdomyosarcoma of the Anterior Mediastinum.

The Journal of the Japanese Society of Clinical Cytology
1998English

P100 Embryonal Rhabdomyosarcoma of the Lung in a Child: Case Report

2019English

Costello Syndrome in Two Brazilian Children.

Journal of Medical Genetics
Genetics
1998English

Survivin Selective Inhibitor YM155 Promotes Cisplatin‑induced Apoptosis in Embryonal Rhabdomyosarcoma

International Journal of Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy